Delivery Order HT942525DE004-HT942525FE075
- Not listed
- The Defense Health Agency awarded Octapharma USA Inc. a delivery order on September 16, 2025, to supply 1,600 units of Octaplas LG kits with a ceiling value of $1.6 million. The contract is priced on a firm fixed-price basis with an ultimate completion date of January 16, 2026, and will be performed at Travis Air Force Base in Fairfield, California. No small business set-aside was utilized for this procurement. Octaplas LG is a liquid plasma product used for transfusion in medical settings to...
- This delivery order, awarded on July 22, 2025, represents a firm fixed-price purchase of medical supply items valued at $7,589.02, with an ultimate completion date of August 12, 2025. The order was issued to Owens & Minor Distribution Inc., a healthcare solutions provider specializing in medical and surgical supply distribution, and was funded by the Defense Logistics Agency's Medical Supply Chain division. The specific product being procured is a low-titer type O blood product in 9-ounce...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to Altitude Technologies Inc. (doing business as Chinook Medical Gear) on August 13, 2025, for single blood-pack units containing 450 milliliters of citrate phosphate dextrose solution. The contract, valued at $3,688.32, represents a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of September 3, 2025. Performance will occur at the contractor's facility in...
- The Defense Health Agency awarded a $9.7 million firm fixed price contract to Vascular Solutions LLC (a Teleflex Medical division) on September 9, 2020, for freeze dried plasma commercial viability activities. The contract, which extends through December 31, 2025, supports the development and commercialization of freeze dried plasma products and related activities. The work is being performed in Maple Grove, Minnesota, and no set-aside designation was used for this award. This contract...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $1,125.10 to Dove Medical Supply LLC on August 6, 2025, for the procurement of 5-vial human plasma with an ultimate completion date of August 20, 2025. This fixed-price contract with economic price adjustment represents a task order issued under Dove Medical Supply LLC's larger Indefinite Delivery/Indefinite Quantity (IDIQ) agreement (SPE2DE21D0022) with the Defense Logistics Agency Troop Support Medical,...
- The Defense Health Agency awarded a $39,282.35 firm fixed-price purchase order to Haemonetics Corporation for hemostasis supplies. The award, issued on August 8, 2025, with an ultimate completion date of August 8, 2025, represents a straightforward procurement with no set-aside designation, indicating open and competitive bidding. Performance will take place in Bethesda, Maryland. Haemonetics, a Boston-based medical technology leader, specializes in blood and plasma management products and is...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1.84K to Altitude Technologies Inc. (doing business as Chinook Medical Gear) on June 5, 2025, for the procurement of single blood-pack units containing 450 milliliters of CPD (citrate phosphate dextrose) anticoagulant solution. The contract, issued without a set-aside designation, reflects the contractor's competitive capabilities in specialized medical supply procurement. Performance is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to Altitude Technologies Inc. (doing business as Chinook Medical Gear) on September 2, 2025, for a single blood-pack unit of 450 milliliters CPD (citrate phosphate dextrose), with a contract ceiling value of $1,844.16. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is scheduled for completion by September 22, 2025. This award was made without a set-aside...
- The U.S. Defense Logistics Agency awarded a delivery order to Altitude Technologies Inc., doing business as Chinook Medical Gear, for a single blood-pack unit of 450mL CPD (citrate phosphate dextrose) with a ceiling value of $3,688.32. The contract, awarded on August 18, 2025, with an ultimate completion date of September 8, 2025, is structured as a fixed-price agreement with economic price adjustment provisions. The work will be performed in Tulsa, Oklahoma. This delivery order was issued...
- The Defense Health Agency, a component of the Department of Defense, awarded a $24,028 purchase order to Haemonetics Corporation for the delivery of 325ml of DE-GLYCE. Performance will take place in Bethesda, Maryland under firm fixed pricing. As a leading provider of blood and plasma collection, processing and delivery technologies, Haemonetics will supply the contracted medical device and consumables to support the Agency's health care programs. No subcontractors or set aside designations were...
- HT942525DE004Indefinite Delivery Contract
- HT942525DE004-HT942525FE075Delivery Order
The Defense Health Agency has awarded a $1.8M delivery order to Octapharma USA Inc. for the procurement of OctaPlasLG, a blood plasma product, supporting the Program Executive Office for Operational Medicine. This is the third task order under the existing contract vehicle, with a firm fixed price structure and no set-aside designation. The contract is scheduled for completion by May 24, 2026, with performance taking place at McGuire Air Force Base in New Jersey. OctaPlasLG is a solvent/detergent-treated plasma product used for treating coagulopathies and plasma deficiencies in military medical settings. The Program Executive Office for Operational Medicine procures medical supplies and equipment to support combat casualty care and operational readiness across the Department of Defense. This delivery order reflects the continued need for blood plasma products within the military health system to maintain inventory levels and ensure availability for both routine and emergency medical procedures at military treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8m | 9/24/25 |